Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Resumen

Parkinson's disease (PD) is associated with emotional abnormalities. Dopaminergic medications ameliorate Parkinsonian motor symptoms, but less is known regarding the impact of dopaminergic agents on affective processing, particularly in depressed PD (dPD) patients. The aim of this study was to examine the effects of dopaminergic pharmacotherapy on brain activation to emotional stimuli in depressed versus nondepressed Parkinson disease (ndPD) patients. Participants included 18 ndPD patients (11 men, 7 women) and 10 dPD patients (7 men, 3 women). Patients viewed photographs of emotional faces during functional MRI. Scans were performed while the patient was taking anti-Parkinson medication and the day after medication had been temporarily discontinued. Results indicate that dopaminergic medications have opposite effects in the prefrontal cortex depending upon depression status. DPD patients show greater deactivation in the ventromedial prefrontal cortex (VMPFC) on dopaminergic medications than off, while ndPD patients show greater deactivation in this region off drugs. The VMPFC is in the default-mode network (DMN). DMN activity is negatively correlated with activity in brain systems used for external visual attention. Thus dopaminergic medications may promote increased attention to external visual stimuli among dPD patients but impede normal suppression of DMN activity during external stimulation among ndPD patients.

Idioma originalEnglish
Número de artículo513452
PublicaciónParkinson's Disease
Volumen2015
DOI
EstadoPublished - 2015

Nota bibliográfica

Publisher Copyright:
© 2015 Anders H. Andersen et al.

Financiación

This work was supported by the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke Grant R01MH78228 (Lee X. Blonder) and by the Department of Veterans Affairs (John T. Slevin).

FinanciadoresNúmero del financiador
National Institute of Mental Health
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke CouncilR01MH78228
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council
U.S. Department of Veterans Affairs

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Neuroscience (miscellaneous)
    • Clinical Neurology
    • Psychiatry and Mental health

    Huella

    Profundice en los temas de investigación de 'Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression'. En conjunto forman una huella única.

    Citar esto